GEMIX
Price
$37.95
Change
+$0.04 (+0.11%)
Updated
Aug 26 closing price
Net Assets
3.31B
VEMIX
Price
$38.27
Change
+$0.08 (+0.21%)
Updated
Aug 26 closing price
Net Assets
162.03B
Interact to see
Advertisement

GEMIX vs VEMIX

GEMIX vs VEMIX Comparison Chart in %
View a ticker or compare two or three
VS
GEMIX vs. VEMIX commentary
Aug 28, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GEMIX is a Hold and VEMIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMIX has more cash in the bank: 162B vs. GEMIX (3.31B). VEMIX pays higher dividends than GEMIX: VEMIX (2.35) vs GEMIX (0.65). GEMIX was incepted earlier than VEMIX: GEMIX (29 years) vs VEMIX (26 years). GEMIX (1.12) is less costly to investors than VEMIX (0.06). GEMIX is a more actively managed with annual turnover of: 43.00 vs. VEMIX (6.00). GEMIX has a lower initial minimum investment than VEMIX: GEMIX (1000000) vs VEMIX (5000000). GEMIX annual gain was more profitable for investors over the last year : 38.62 vs. VEMIX (18.54). VEMIX return over 5 years is better than : 31.01 vs. GEMIX (27.11).
GEMIXVEMIXGEMIX / VEMIX
Total Expense Ratio1.030.061,717%
Annual Report Gross Expense Ratio1.120.061,867%
Fund Existence29 years26 years-
Gain YTD24.37712.676192%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets3.31B162B2%
Annual Yield % from dividends0.652.3528%
Returns for 1 year38.6218.54208%
Returns for 3 years87.9859.89147%
Returns for 5 years27.1131.0187%
Returns for 10 years142.1191.07156%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICPAX9.080.11
+1.23%
Integrity Mid-North American Resources A
AEIMX9.700.02
+0.21%
American Century Equity Income G
DDVAX13.100.01
+0.08%
Nomura Value A
SSCCX0.41N/A
N/A
Saratoga Small Capitalization C
TCMHX20.65N/A
N/A
Nuveen Quant Mid Cap Growth I